跳至主要内容
临床试验/NCT04934163
NCT04934163已完成不适用

Effect of Flow Rates of Postextubation High-flow Nasal Cannula on Extubation Outcome: An Open-label, Randomized Controlled Trial

National Taiwan University Hospital2 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2021年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
180
试验地点
2
主要终点
A composite outcome of NIV(non-invasive ventilation) use or reintubation in 48 hours

研究概览

简要总结

This is a single-center, open-label, randomized controlled trial to evaluate the effect of high-flow nasal cannula with a flow rate of 60 L/min versus 40 L/min after planned extubationon on a composite outcome of reintubation and use of NIV.

详细描述

This is a single-center, open-label, randomized controlled trial to evaluate the effect of high-flow nasal cannula with a flow rate of 60 L/min versus 40 L/min after planned extubationon on a composite outcome of reintubation and use of NIV in patients who are intubated for hypoxemic respiratory failure.

[Study Procedures] Set flow rates of HFNC The flow rates of HFNC(high-flow nasal cannula) are set as 40 L/min and 60 L/min, respectively in the two trial groups. FiO2 was down-titrated to the minimal level to keep SO2 ≥ 92%. After that, the flow rate setting is fixed for 24hrs +/- 6 hrs in the two groups. After that, the flow rate setting in both groups would be tapered to 30 L/min and would be kept for 12 hours. Then, HFNC would be changed to conventional oxygen therapy to keep SpO2≥ 92%.

[Outcome Measures] To increase the statistical power of this pilot trial, we used a composite outcome of NIV use and or reintubation in 48 hours for the primary endpoint. Secondary endpoints include mortality of different time points, physiological parameters(respiratory rate, heart rate), ventilation/oxygenation data(PaO2/FiO2 ratio, pH) and patient comfort. Exploratory endpoints include comparison between different flow rate settings.

[Primary endpoint] We hypothesized that higher flow setting of HFNC can reduce work of breathing and can increase washout of dead space, which could result in lower re-intubation rate and lower NIV use rate after planned extubation in hypoxemic patients. The primary endpoint is a composite outcome of NIV use or reintubation in 48 hours between two groups of different flow rates.

[Secondary endpoints] ICU mortality In-hospital mortality 28-day mortality Time to successful liberation from mechanical ventilation AUC(area under curve) of respiratory rate (0-24 hours) AUC of heart rate (0-24 hours) PaO2/FiO2 ratio at 4 and 24 hours Change of arterial CO2 level(mmHg) at 4 and 24 hours Proportion of respiratory acidosis (arterial blood gas: pH<7.35) at 4 and 24 hours Proportion of Intolerance (up titration of flow or/and FiO2; down titration of flow) in 24 hours

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • invasive mechanical ventilation > 48 hours
  • acute hypoxemic respiratory failure(PaO2/FiO2 < 300 mmHg) as a main cause of invasive mechanical ventilation.
  • planned extubation & already passed a spontaneous breathing trial (SBT)

排除标准

  • < 20 years of ages
  • refusal to re-intubation
  • with terminal cancer
  • pregnant women
  • with a tracheal stoma or tracheostomy tube in situ
  • not feasible for high-flow nasal cannula(decided by the primary care team)
  • must required to use non-invasive ventilation immediately after extubation (decided by the primary care team)

结局指标

主要结局

A composite outcome of NIV(non-invasive ventilation) use or reintubation in 48 hours

时间窗: 48 hours after extubation

Proportion of patients require NIV(non-invasive ventilation) support or reintubation

次要结局

  • Time to successful liberation from mechanical ventilation(28 days)
  • AUC(area under curve) of respiratory rate (0-24 hours)(24 hours)
  • Proportion of respiratory acidosis (arterial blood gas: pH<7.35) in 24 hours(24 hours)
  • ICU mortality(ICU stay)
  • In-hospital mortality(Hospital stay)
  • 28-day mortality(28 days)
  • Change of arterial CO2 level(mmHg) between 0 and 24th hour(24 hours)
  • AUC of heart rate (0-24 hours)(24 hours)
  • Change of PaO2/FiO2 ratio between 0 and 24th hour(24 hours)
  • Proportion of Intolerance in 24 hours(24 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Flow Rates of High-flow Nasal Cannula and Extubation... | 临床试验